In a groundbreaking shift within the healthcare sector, the neurology digital therapeutics market is set to experience an unprecedented surge. Recent research by FMI forecasts a dynamic 9.0% growth annually from 2021 to 2031, signaling a transformative era in the management and prevention of neurological conditions using advanced information and communication technology.
Neurology digital therapeutics represents the forefront of innovative healthcare, leveraging digital platforms to deliver evidence-based therapeutic interventions. These cutting-edge solutions are designed to improve patient outcomes by providing personalized, accessible, and scalable treatments for a wide range of neurological disorders, including Alzheimer’s, Parkinson’s, epilepsy, and more.
The FMI report highlights that the increased adoption of digital health solutions and the ongoing development of sophisticated therapeutic technologies are major drivers behind this growth. The report also underscores the potential of these technologies to transform patient care, offering more efficient and personalized treatment options.
Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14231
Industry experts believe that this growth will lead to significant improvements in the management of neurological conditions, providing new opportunities for healthcare providers and patients alike. As the healthcare landscape continues to evolve, neurology digital therapeutics is set to play a crucial role in shaping the future of medical treatment.
Addressing Blood Flow Issues: Intravascular Embolization Systems Offer Minimally Invasive Solutions
The global intravascular embolization systems market is experiencing growth, fueled by the increasing adoption of minimally invasive procedures for treating various vascular conditions. Intravascular embolization is a technique used to block abnormal blood flow within vessels by deploying coils, plugs, or balloons. This approach offers a less invasive alternative to traditional open surgery for conditions like bleeding, vascular malformations, and tumors.
East Asia Emerging as a Growth Hub
The intravascular embolization systems market is expected to witness significant growth in East Asia. This region is experiencing a surge in healthcare standards, with developing countries like Japan and China investing heavily in advanced medical technologies. This, coupled with a growing aging population at risk for vascular ailments, is creating a strong demand for minimally invasive treatment options like intravascular embolization.
Key Takeaways:
- The global intravascular embolization systems market is expected to reach US$5,861.41 million by 2032, reflecting a rise from US$2,920.44 million in 2022.
- This growth is projected at a steady compound annual growth rate (CAGR) of 7.2% throughout the forecast period.
- The rising demand in East Asia, driven by advancements in healthcare infrastructure, is a key driver for market expansion.
The key players of neurology digital therapeutics include:
- Livongo Health
- Noom
- Omada Health
- Pear Therapeutics
- WellDoc
- Proteus Digital Health
- Propeller Health
- Akili Interactive Labs
- Mango Health
- Better Therapeutics
- Happify
- Kaia Health
- Click Therapeutics and others.
They follow certain strategies to survive in the market like a product launch, product approval, patent gaining, expansion, acquisition and merger. For instance, in October 2021, Pear Therapeutics announced about continuing the expansion of intellectual property portfolio for prescription digital therapeutics.
Key Segments:
By Product Type:
- Software
- Devices
By Indication:
- Diabetes
- Obesity
- Cardiovascular Disease (CVD)
- Central Nervous System (CNS) Disease
- Respiratory Disease
- Others
By End User:
- Hospital
- Clinics
- Others
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- MEA